For the Inventor, By the Inventor

Enter assignee name

Mendrisio, Switzerland

Sintetica S.a.

USPTO Granted Patents = 16

EPO Patents = 6

Trademarks = 3

Forward Citations = 317

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Augusto Mitidieri (12 out of 12 patents)

Elisabetta Donati (10 out of 15 patents)

Nicola Caronzolo (7 out of 7 patents)

4. Clara Bianchi (4 out of 4 patents)

5. Elisabetta Donati (2 out of 2 patents)

6. Philippe Bussat (1 out of 65 patents)

7. Michel Schneider (1 out of 79 patents)

8. Herve Tournier (1 out of 28 patents)

9. Jerome Puginier (1 out of 21 patents)

10. Daniel Bichon (1 out of 41 patents)

11. Barbara Piccagli (1 out of 1 patent)

12. Claude Giddey (1 out of 16 patents)

13. Georges Dove (1 out of 10 patents)

14. Eva Hybl-Sutherland (1 out of 8 patents)

15. Friedrich Cavagna (1 out of 4 patents)

16 patents: Sort by Forward Citations

1. 12564561 - Dilute ready to use large volume containers of phenylephrine (2026-03-03),

2. 11969403 - Topical formulations of chloroprocaine and methods of using same (2024-04-30),

3. RE49555 - Process for producing a stable low concentration, injectable solution of noradrenaline (2023-06-19),

4. RE49443 - Process for producing a stable low concentration, injectable solution of noradrenaline (2023-03-06),

5. 11590105 - Intrathecal administration of levetiracetam (2023-02-28),

6. RE49422 - Process for producing a stable low concentration, injectable solution of noradrenaline (2023-02-20),

7. 11344517 - Injectable supersaturated acetaminophen solution for spinal administration (2022-05-31),

8. 10792271 - Topical formulations of chloroprocaine and methods of using same (2020-10-06),

9. 10251848 - Process for producing a stable low concentration, injectable solution of noradrenaline (2019-04-09),

10. 9856124 - Device for opening glass ampoules (2018-01-02),

11. 9504666 - Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration (2016-11-29),

12. 8969412 - Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture (2015-03-03),

13. 8263660 - Stable hyperbaric composition comprising prilocaine HCl, use of said new composition for intrathecal anaethesia, and method for manufacturing said composition (2012-09-11),

14. 5653959 - Compositions for increasing the image contrast in diagnostic (1997-08-05),

15. 5310540 - Method for the preparation of stable suspensions of hollow gas-filled (1994-05-10),

Company Overview

Sintetica S.a., based in Mendrisio, Switzerland, specializes in the development and manufacturing of high-quality pharmaceuticals. The company focuses on innovative solutions in the fields of anesthesia, pain management, and critical care, aiming to enhance patient outcomes through advanced medical products. Sintetica is committed to research and development, leveraging cutting-edge technology to address the evolving needs of healthcare professionals and patients globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

16 Patents

#2 in Mendrisio

#802 in Switzerland

#37,831 in the World

Mendrisio, Switzerland

Sintetica S.a.

Forward Citations = 317

16 inventors:

Augusto Mitidieri (12 out of 12 patents)

Elisabetta Donati (10 out of 15 patents)

Nicola Caronzolo (7 out of 7 patents)

4. Clara Bianchi (4 out of 4 patents)

5. Elisabetta Donati (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sintetica S.a.. Retrieved from https://idiyas.com/company/sintetica-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…